26.12.2012 Views

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

484<br />

Haufroid et al. (2001) examined possible influences of genetic polymorphisms in<br />

metabolic enzymes on the metabolism of styrene (average concentration, 18.2 ppm<br />

[77.5 mg/m 3 ]) in 30 workers from a glass fibre-reinforced plastics factory. The presence<br />

of the rare CYP2E1*1B allele was associated with increased excretion of urinary<br />

mandelic and phenylglyoxylic acids as well as mercapturic acid metabolites. Individuals<br />

deficient in glutathione S-transferase (GST) M1 excreted less than one-half the amount<br />

of mercapturic acids, a minor pathway in humans, compared with GSTM1– proficient<br />

individuals.<br />

De Palma et al. (2001) examined polymorphisms in GSTM1-1 and T1-1 and microsomal<br />

epoxide hydrolase in 56 styrene-exposed workers (geometric mean exposure,<br />

157 mg/m 3 , time-weighted average over 8 h). GSTM1-1 was identified as the primary<br />

isozyme for conjugation of glutathione with styrene 7,8-oxide. Workers who were positive<br />

for GSTM1-1 excreted 5–6 times more phenylhydroxyethylmercapturic acids than<br />

did individuals who were GSTM1-1-deficient. No association was found between microsomal<br />

epoxide hydrolase polymorphisms and excretion of the mercapturic acids.<br />

(d ) Excretion<br />

Only small amounts of styrene (0.7–4.4%) are exhaled unchanged (see <strong>IARC</strong>, 1994a<br />

for details). This has been confirmed in more recent studies, in which 0.7–2.2% of the<br />

amount of inhaled styrene was found unchanged in the exhaled breath of four subjects<br />

exposed to 50 ppm [213 mg/m 3 ] styrene for 2 h (Johanson et al., 2000). Small amounts<br />

of styrene are also excreted unmetabolized in the urine (Pezzagno et al., 1985; Gobba<br />

et al. 1993). Ramsey et al. (1980) examined the pharmacokinetics of inhaled styrene<br />

(80 ppm [341 mg/m 3 ]) in four human volunteers and calculated half-life values of 0.6 and<br />

13.0 h for the two phases of elimination.<br />

Brugnone et al. (1993) measured styrene concentrations in blood of 76 exposed<br />

workers at the end of the work shift and the morning after, and reported a half-life of elimination<br />

of 3.9 h.<br />

4.1.2 Experimental systems<br />

(a) Absorption<br />

<strong>IARC</strong> <strong>M<strong>ON</strong>OGRAPHS</strong> VOLUME 82<br />

McDougal et al. (1990) compared the dermal absorption of vapours from several<br />

organic chemicals in male Fischer 344 rats. The animals breathed fresh air through a<br />

latex mask. For styrene (3000 ppm [12 800 mg/m 3 ] for 4 h), a maximal blood concentration<br />

of about 10 μg/mL and a permeability constant of 1.753 cm/h were reported. In a<br />

mixed exposure situation (inhalation and skin absorption), the skin uptake was estimated<br />

to account for 9.4% of the total uptake in these rats. Morgan et al. (1991) examined the<br />

dermal absorption of styrene in Fischer 344 rats. When administered neat (2 mL of<br />

styrene in a sealed dermal cell), the peak blood level of styrene, reached after 1 h, was<br />

5.3 μg/mL. Absorption decreased when the styrene was diluted with water.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!